Role of metal dyshomeostasis in Alzheimer's disease

Metallomics

Volumn 3, Issue 3, 2011, Pages 267-270

  Bonda, David J ^a   Lee, Hyoung Gon ^a   Blair, Jeffrey A ^a   Zhu, Xiongwei ^a   Perry, George ^a,b   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE-RELATED; ALZHEIMER'S DISEASE; CELLULAR FUNCTION; CRITICAL FACTORS; METAL HOMEOSTASIS; NEURODEGENERATIVE; STRESS-INDUCED DAMAGE;

METALS; NEURODEGENERATIVE DISEASES; OLIGOMERIZATION; OLIGOMERS; ZINC;

COPPER;

AMYLOID BETA PROTEIN; CHELATING AGENT; COPPER; DEFERIPRONE; DEFEROXAMINE; IRON; NANOPARTICLE; TRANSITION ELEMENT; ZINC;

AGING; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL DAMAGE; CHELATION THERAPY; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG SOLUBILITY; HUMAN; METAL BINDING; NEUROBIOLOGY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; CHELATING AGENTS; COPPER; HUMANS; IRON; ZINC;

EID: 79952528994     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c0mt00074d     Document Type: Review

References (50)

1. R. J. Castellani R. K. Rolston M. A. Smith Alzheimer disease Dis. Mon. 2010 56 484 546
2. H. G. Lee G. Casadesus X. Zhu A. Takeda G. Perry M. A. Smith Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease Ann. N. Y. Acad. Sci. 2004 1019 1 4 (Pubitemid 38951274)
3. R. J. Castellani H. G. Lee S. L. Siedlak A. Nunomura T. Hayashi M. Nakamura X. Zhu G. Perry M. A. Smith Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta J. Alzheimers Dis. 2009 18 447 452
4. M. A. Smith P. L. Harris L. M. Sayre G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. U. S. A. 1997 94 9866 9868 (Pubitemid 27408156)
5. M. A. Smith K. Wehr P. L. Harris S. L. Siedlak J. R. Connor G. Perry Abnormal localization of iron regulatory protein in Alzheimer's disease Brain Res. 1998 788 232 236 (Pubitemid 28202166)
6. M. A. Lovell J. D. Robertson W. J. Teesdale J. L. Campbell W. R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 1998 158 47 52 (Pubitemid 28277534)
7. L. M. Sayre G. Perry P. L. Harris Y. Liu K. A. Schubert M. A. Smith In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals J. Neurochem. 2000 74 270 279 (Pubitemid 30012778)
8. G. Perry L. M. Sayre C. S. Atwood R. J. Castellani A. D. Cash C. A. Rottkamp M. A. Smith The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications CNS Drugs 2002 16 339 352 (Pubitemid 34548201)
9. P. M. Doraiswamy A. E. Finefrock Metals in our minds: therapeutic implications for neurodegenerative disorders Lancet Neurol. 2004 3 431 434 (Pubitemid 38789138)
10. X. Zhu R. J. Castellani A. Takeda A. Nunomura C. S. Atwood G. Perry M. A. Smith Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis Mech. Ageing Dev. 2001 123 39 46 (Pubitemid 32972257)
11. X. Zhu H. G. Lee G. Perry M. A. Smith Alzheimer disease, the two-hit hypothesis: an update Biochim. Biophys. Acta 2007 1772 494 502 (Pubitemid 46400383)
12. X. Zhu A. K. Raina G. Perry M. A. Smith Alzheimer's disease: the two-hit hypothesis Lancet Neurol. 2004 3 219 226 (Pubitemid 38373660)
13. H. G. Lee X. Zhu R. J. Castellani A. Nunomura G. Perry M. A. Smith Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses J. Pharmacol. Exp. Ther. 2007 321 823 829 (Pubitemid 46762675)
14. C. W. Olanow An introduction to the free radical hypothesis in Parkinson's disease Ann. Neurol. 1992 32 Suppl. S2 9
15. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York, 1999
16. X. Zhu B. Su X. Wang M. A. Smith G. Perry Causes of oxidative stress in Alzheimer disease Cell. Mol. Life Sci. 2007 64 2202 2210 (Pubitemid 47347959)
17. X. Huang R. D. Moir R. E. Tanzi A. I. Bush J. T. Rogers Redox-active metals, oxidative stress, and Alzheimer's disease pathology Ann. N. Y. Acad. Sci. 2004 1012 153 163 (Pubitemid 38453522)
18. B. F. Gh Popescu H. Nichol Mapping brain metals to evaluate therapies for neurodegenerative disease CNS neuroscience & therapeutics 2010 10.1111/j.1755-5949.2010.00149.x
19. J. T. Rogers J. D. Randall C. M. Cahill P. S. Eder X. Huang H. Gunshin L. Leiter J. McPhee S. S. Sarang T. Utsuki N. H. Greig D. K. Lahiri R. E. Tanzi A. I. Bush T. Giordano S. R. Gullans An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript J. Biol. Chem. 2002 277 45518 45528 (Pubitemid 36159162)
20. J. A. Duce A. Tsatsanis M. A. Cater S. A. James E. Robb K. Wikhe S. L. Leong K. Perez T. Johanssen M. A. Greenough H. H. Cho D. Galatis R. D. Moir C. L. Masters C. McLean R. E. Tanzi R. Cappai K. J. Barnham G. D. Ciccotosto J. T. Rogers A. I. Bush Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 2010 142 857 867
21. M. Takahashi S. Dore C. D. Ferris T. Tomita A. Sawa H. Wolosker D. R. Borchelt T. Iwatsubo S. H. Kim G. Thinakaran S. S. Sisodia S. H. Snyder Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease Neuron 2000 28 461 473
22. P. W. Mantyh J. R. Ghilardi S. Rogers E. DeMaster C. J. Allen E. R. Stimson J. E. Maggio Aluminium, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide J. Neurochem. 1993 61 1171 1174 (Pubitemid 23241264)
23. C. J. Lin H. C. Huang Z. F. Jiang Cu(ii) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains Brain Res. Bull. 2010 82 235 242 10.1016/j.brainresbull.2010.06.003
24. Y. Miller B. Ma R. Nussinov Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states Proc. Natl. Acad. Sci. U. S. A. 2010 107 9490 9495 10.1073/pnas.0913114107
25. T. Marino N. Russo M. Toscano M. Pavelka On the metal ion (Zn(2+), Cu(2+)) coordination with beta-amyloid peptide: DFT computational study Interdiscip. Sci. 2010 2 57 69 10.1007/s12539-010-0086-x
26. C. S. Atwood R. D. Moir X. Huang R. C. Scarpa N. M. Bacarra D. M. Romano M. A. Hartshorn R. E. Tanzi A. I. Bush Dramatic aggregation of Alzheimer abeta by Cu(ii) is induced by conditions representing physiological acidosis J. Biol. Chem. 1998 273 12817 12826 (Pubitemid 28246837)
27. Z. Zheng C. White J. Lee T. S. Peterson A. I. Bush G. Y. Sun G. A. Weisman M. J. Petris Altered microglial copper homeostasis in a mouse model of Alzheimer's disease J. Neurochem. 2010 114 1630 1638 10.1111/j.1471-4159.2010. 06888.x
28. D. J. Bonda X. Wang G. Perry A. Nunomura M. Tabaton X. Zhu M. A. Smith Oxidative stress in Alzheimer disease: a possibility for prevention Neuropharmacology 2010 59 290 294
29. C. Hureau P. Faller Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease Biochimie 2009 91 1212 1217 10.1016/j.biochi.2009.03.013
30. J. A. Duce A. I. Bush Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics Prog. Neurobiol. 2010 92 1 18 10.1016/j.pneurobio.2010.04.003
31. G. Liu P. Men G. Perry M. A. Smith Nanoparticle and iron chelators as a potential novel Alzheimer therapy Methods Mol. Biol. 2010 610 123 144
32. H. Keberle The Biochemistry Of Desferrioxamine And Its Relation To Iron Metabolism Ann. N. Y. Acad. Sci. 1964 119 758 768
33. D. R. McLachlan T. P. Kruck W. J. Lukiw S. S. Krishnan Would decreased aluminium ingestion reduce the incidence of Alzheimer's disease? CMAJ 1991 145 793 804
34. M. P. Cuajungco K. Y. Faget X. Huang R. E. Tanzi A. I. Bush Metal chelation as a potential therapy for Alzheimer's disease Ann. N. Y. Acad. Sci. 2000 920 292 304 (Pubitemid 32056584)
35. D. R. Richardson P. Ponka Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism Am. J. Hematol. 1998 58 299 305 (Pubitemid 28346017)
36. N. F. Olivieri G. M. Brittenham Iron-chelating therapy and the treatment of thalassemia Blood 1997 89 739 761 (Pubitemid 27121266)
37. G. J. Kontoghiorghes New concepts of iron and aluminium chelation therapy with oral L1 (deferiprone) and other chelators A review Analyst 1995 120 845 851
38. R. C. Hider, J. B. Porter and S. Singh, in The development of iron chelators for clinical use, ed., R. J. Bergeron, and, G. M. Brittenham,, CRC, Boca Raton, 1994, pp. 353-371
39. P. Reichard Interactions between deoxyribonucleotide and DNA synthesis Annu. Rev. Biochem. 1988 57 349 374
40. J. Stubbe Ribonucleotide reductases: amazing and confusing J. Biol. Chem. 1990 265 5329 5332
41. K. P. Hoyes R. C. Hider J. B. Porter Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines Cancer Res. 1992 52 4591 4599
42. C. E. Cooper G. R. Lynagh K. P. Hoyes R. C. Hider R. Cammack J. B. Porter The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase J. Biol. Chem. 1996 271 20291 20299 (Pubitemid 26281794)
43. C. Gerez M. Fontecave Reduction of the small subunit of Escherichia coli ribonucleotide reductase by hydrazines and hydroxylamines Biochemistry 1992 31 780 786
44. J. B. Porter M. Gyparaki L. C. Burke E. R. Huehns P. Sarpong V. Saez R. C. Hider Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant Blood 1988 72 1497 1503 (Pubitemid 18268625)
45. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Delivery Rev. 2001 47 65 81 (Pubitemid 32209233)
46. J. Kreuter D. Shamenkov V. Petrov P. Ramge K. Cychutek C. Koch-Brandt R. Alyautdin Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Targeting 2002 10 317 325 (Pubitemid 34746313)
47. R. N. Alyaudtin A. Reichel R. Lobenberg P. Ramge J. Kreuter D. J. Begley Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro J. Drug Targeting 2001 9 209 221 (Pubitemid 32776368)
48. J. Kreuter R. N. Alyautdin D. A. Kharkevich A. A. Ivanov Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) Brain Res. 1995 674 171 174
49. P. Ramge R. E. Unger J. B. Oltrogge D. Zenker D. Begley J. Kreuter H. Von Briesen Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells Eur. J. Neurosci. 2000 12 1931 1940 (Pubitemid 30348832)
50. G. Liu P. Men G. Perry M. A. Smith Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease Prog. Brain Res. 2009 180 97 108